© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Syndicated Loans

More articles

More articles

More articles

  • Leveraged finance markets are set for a fresh stream of buyout deals in the software industry next year, with Europe becoming a busier playground for US private equity firms.
  • Austria’s Verbund has joined the ESG-linked revolving credit facility fray, with the electricity company signing what leads say is the first such deal in the country.
  • GlaxoSmithKline and Pfizer have agreed to combine their consumer health businesses to create a market leading joint venture with sales of around £9.8bn. The companies expect to divest assets to cover the cash cost of the integration.
  • Russian Copper Co (RCC) has closed a $250m five year credit facility, marking the second refinancing that RCC has secured this year. The tight margin sparked a sliver of optimism in the market.
  • Conditions have rarely been sweeter for European borrowers seeking to diversify their funding sources. Europe’s dominant private debt markets for investment grade issuers, the US private placement market and the Schuldschein, are thriving, and agents in both are on the hunt for new borrowers. Their search will better if, as expected, public bond markets have a tough 2019. Silas Brown reports.
  • Mergers and acquisitions in Europe are back. But what loans bankers have long hoped would be great news for their businesses is in most cases turning out to be a far less lucrative development, as companies increasingly turn to smaller banking groups to finance their acquisition plans. By Michael Turner.